Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 13, 2017, Pages E2786-E2795

  Daley Bauer, Lisa P ^a   Roback, Linda ^a   Crosby, Lynsey N ^a   McCormick, A Louise ^a   Feng, Yanjun ^a   Kaiser, William J ^a   Mocarski, Edward S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caspase 8; Cell death; Inflammation; MCMV; RIP3 kinase

Indexed keywords

ANTIVIRUS AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MIXED LINEAGE KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; M36 PROTEIN, MOUSE CYTOMEGALOVIRUS; M45 PROTEIN, MOUSE CYTOMEGALOVIRUS 1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIBONUCLEOTIDE REDUCTASE; RIPK3 PROTEIN, MOUSE; VIRAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNE RESPONSE; INFECTION PREVENTION; INFLAMMATION; MACROPHAGE; MOUSE; MURINE CYTOMEGALOVIRUS; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS MUTANT; ANIMAL; CLASSIFICATION; GENETICS; HERPES VIRUS INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MUROMEGALOVIRUS; PATHOPHYSIOLOGY; RODENT DISEASE; VETERINARY; VIROLOGY;

ANIMALS; APOPTOSIS; CASPASE 8; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; MICE; MUROMEGALOVIRUS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RIBONUCLEOTIDE REDUCTASES; RODENT DISEASES; VIRAL PROTEINS;

EID: 85016415539     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1616829114     Document Type: Article

References (46)

1. Mocarski ES, Guo H, Kaiser WJ (2015) Necroptosis: The Trojan horse in cell autonomous antiviral host defense. Virology 479-480:160-166.
2. Sun X, et al. (1999) RIP3, a novel apoptosis-inducing kinase. J Biol Chem 274(24): 16871-16875.
3. Newton K, et al. (2014) Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343(6177):1357-1360.
4. Mandal P, et al. (2014) RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 56(4):481-495.
5. Nogusa S, et al. (2016) RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. Cell Host Microbe 20(1):13-24.
6. Upton JW, Kaiser WJ, Mocarski ES (2008) Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 283(25):16966-16970.
7. Upton JW, Kaiser WJ, Mocarski ES (2010) Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7(4):302-313.
8. Upton JW, Kaiser WJ, Mocarski ES (2012) DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11(3):290-297.
9. Kaiser WJ, et al. (2011) RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471(7338):368-372.
10. Oberst A, et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471(7338):363-367.
11. Zhang H, et al. (2011) Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471(7338):373-376.
12. Cho YS, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137(6): 1112-1123.
13. Zhang DW, et al. (2009) RIP3, an energy metabolism regulator that switches TNFinduced cell death from apoptosis to necrosis. Science 325(5938):332-336.
14. He S, et al. (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137(6):1100-1111.
15. Kaiser WJ, et al. (2013) Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 288(43):31268-31279.
16. Guo H, Kaiser WJ, Mocarski ES (2015) Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (Berl) 204(3):439-448.
17. Skaletskaya A, et al. (2001) A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci USA 98(14):7829-7834.
18. Langelier Y, et al. (2002) The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J Gen Virol 83(Pt 11):2779-2789.
19. Mocarski ES, Upton JW, Kaiser WJ (2011) Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 12(2):79-88.
20. Rebsamen M, et al. (2009) DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 10(8):916-922.
21. Krause E, de Graaf M, Fliss PM, Dölken L, Brune W (2014) Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection. J Virol 88(17):9963-9975.
22. Ebermann L, et al. (2012) Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. PLoS Pathog 8(12):e1003062.
23. Cicin-Sain L, et al. (2008) Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol 82(5):2056-2064.
24. Ménard C, et al. (2003) Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol 77(10):5557-5570.
25. BruneW, Ménard C, Heesemann J, Koszinowski UH (2001) A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291(5502):303-305.
26. Guo H, et al. (2015) Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe 17(2):243-251.
27. Mocarski ES, Kaiser WJ, Livingston-Rosanoff D, Upton JW, Daley-Bauer LP (2014) True grit: Programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol 192(5):2019-2026.
28. Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES (2014) Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe 15(3):351-362.
29. Daley-Bauer LP, Wynn GM, Mocarski ES (2012) Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity 37(1): 122-133.
30. Li J, et al. (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150(2):339-350.
31. Moriwaki K, Chan FK (2016) Regulation of RIPK3-and RHIM-dependent necroptosis by the proteasome. J Biol Chem 291(11):5948-5959.
32. Feoktistova M, et al. (2011) cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43(3):449-463.
33. Tenev T, et al. (2011) The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43(3):432-448.
34. Daley-Bauer LP, Mocarski ES (2013) Myeloid cell recruitment and function in cytomegalovirus immunity and pathogenesis. Cytomegaloviruses: From Molecular Pathogenesis to Intervention, ed Reddehase MJ (Caister Scientific Press, Norfolk), Vol I, pp 363-373.
35. McCormick AL, Mocarski ES (2013) Cell death pathways controlled by cytomegaloviruses. Cytomegaloviruses: From Molecular Pathogenesis to Intervention, ed Reddehase MJ (Caister Scientific Press, Norfolk), Vol I, pp 263-276.
36. Omoto S, et al. (2015) Suppression of RIP3-dependent necroptosis by human cytomegalovirus. J Biol Chem 290(18):11635-11648.
37. Lucin P, et al. (1994) Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 75(Pt 1):101-110.
38. McCormick AL, Skaletskaya A, Barry PA, Mocarski ES, Goldmacher VS (2003) Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology 316(2): 221-233.
39. Mack C, Sickmann A, Lembo D, Brune W (2008) Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci USA 105(8):3094-3099.
40. Kaiser WJ, et al. (2014) RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc Natl Acad Sci USA 111(21):7753-7758.
41. Berger SB, et al. (2014) Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192(12):5476-5480.
42. Ishii KJ, et al. (2008) TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451(7179):725-729.
43. Redwood AJ, et al. (2005) Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol 79(5): 2998-3008.
44. Tandon R, Mocarski ES (2008) Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J Virol 82(19):9433-9444.
45. Tischer BK, Smith GA, Osterrieder N (2010) En passant mutagenesis: A two step markerless red recombination system. Methods Mol Biol 634:421-430.
46. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES (1999) Cytomegalovirusencoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 96(19):10881-10886